{"id":"W1994978349","doi":"10.1186/1471-2407-8-195","title":"A single dose of pegfilgrastim compared with daily filgrastim for supporting neutrophil recovery in patients treated for low-to-intermediate risk acute myeloid leukemia: results from a randomized, double-blind, phase 2 trial","year":2008,"lang":"en","type":"article","venue":"BMC Cancer","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"Amgen","keywords":"Filgrastim; Pegfilgrastim; Medicine; Neutropenia; Cytarabine; Febrile neutropenia; Internal medicine; Chemotherapy; Induction chemotherapy; Myeloid leukemia; Surgery; Oncology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002581025,0.001865356,0.002913526,0.0005136984,0.0004065041,0.001201536,0.0009995659,0.002380583,0.00538189],"category_scores_gemma":[0.002902166,0.0008109261,0.001868196,0.0003710077,0.00133986,0.001298701,0.0004691006,0.003195445,0.000941085],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006681185,"about_ca_system_score_gemma":0.00112916,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003904769,"about_ca_topic_score_gemma":0.0007291728,"domain_scores_codex":[0.998949,0.000650585,0.0000718316,0.0001676567,0.00005318883,0.0001077692],"domain_scores_gemma":[0.9978222,0.0008493077,0.0005268651,0.0001740327,0.00008346853,0.0005441554],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9856673,0.005451,0.000224816,0.0001906864,0.0003056352,0.00001381601,0.00002579957,0.0001676201,0.001589812,0.00003135224,0.000237062,0.006095176],"study_design_scores_gemma":[0.9435977,0.05513796,0.0004768637,0.00001122883,0.0001367394,0.00001321703,0.000005770569,0.0002170635,0.0002227045,0.00005026725,0.0001235039,0.000006881115],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9921911,0.002521955,0.0004891873,0.0006506174,0.0004412024,0.002321201,0.0004510139,0.00009889186,0.0008348132],"genre_scores_gemma":[0.9893962,0.001533123,0.001616027,0.0009632133,0.0006005699,0.003777135,0.0006166541,0.00002401679,0.001473142],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00538189,"threshold_uncertainty_score":0.01800418,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04631734565704509,"score_gpt":0.3240688621418412,"score_spread":0.2777515164847961,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}